Utah Retirement Systems Neurocrine Biosciences Inc Transaction History

Utah Retirement Systems

$8.85 Billion
Q4 2024

A detailed history of Utah Retirement Systems transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Utah Retirement Systems holds 16,583 shares of NBIX stock, worth $2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

16,583

Previous 16,483 0.61%

Holding current value

$2 Million

Previous $1.9 Million 19.29%

% of portfolio

0.03%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$111.62 - $139.44 $11,162 - $13,944	100 Added 0.61%	16,583 $2.26 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $26,172 - $28,638	-200 Reduced 1.2%	16,483 $2.27 Million
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $9,402 - $11,710	100 Added 0.6%	16,683 $1.88 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $17,906 - $20,974	-200 Reduced 1.19%	16,583 $1.56 Million
Q4 2022 Feb 15, 2023	SELL	$106.72 - $127.06 $21,344 - $25,412	-200 Reduced 1.18%	16,783 $2 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $27,609 - $32,343	300 Added 1.8%	16,983 $1.8 Million
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $21,735 - $28,443	-300 Reduced 1.77%	16,683 $1.56 Million
Q3 2021 Nov 16, 2021	SELL	$86.18 - $99.03 $68,944 - $79,224	-800 Reduced 4.5%	16,983 $1.63 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $8,943 - $10,227	100 Added 0.57%	17,783 $1.73 Million
Q1 2021 May 17, 2021	SELL	$87.57 - $119.4 $70,056 - $95,520	-800 Reduced 4.33%	17,683 $1.72 Million
Q4 2020 Feb 16, 2021	BUY	$86.91 - $108.33 $69,528 - $86,664	800 Added 4.52%	18,483 $1.77 Million
Q3 2020 Nov 16, 2020	BUY	$96.16 - $135.15 $19,232 - $27,030	200 Added 1.14%	17,683 $1.7 Million
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $25,527 - $39,108	300 Added 1.75%	17,483 $2.13 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $8,382 - $10,150	100 Added 0.59%	17,183 $1.55 Million
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $7,368 - $9,309	102 Added 0.6%	17,083 $1.44 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $26,407 - $34,872	381 Added 2.3%	16,981 $1.5 Million
Q4 2018 Feb 08, 2019	BUY	$68.32 - $124.36 $6,831 - $12,436	100 Added 0.61%	16,600 $1.19 Million
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $15,176 - $18,486	200 Added 1.23%	16,500 $1.37 Million
Q4 2017 Feb 14, 2018	BUY	$58.53 - $77.59 $17,559 - $23,277	300 Added 1.88%	16,300 $1.27 Million
Q3 2017 Nov 13, 2017	BUY	$47.97 - $61.28 $767,520 - $980,480	16,000	16,000 $980,000

Others Institutions Holding NBIX

# of Institutions

654

Shares Held

96.5M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account

Utah Retirement Systems Neurocrine Biosciences Inc Transaction History